🇺🇸 FDA
Patent

US 8143276

4-thio substituted quinoline and naphthyridine compounds

granted A61PA61P31/00

Quick answer

US patent 8143276 (4-thio substituted quinoline and naphthyridine compounds) held by XTL BIOPHARMACEUTICALS LTD. expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
XTL BIOPHARMACEUTICALS LTD.
Grant date
Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P31/00